XML 25 R11.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Restructuring and Integration Costs | 12 Months Ended
--- | ---
Oct. 31, 2015
Restructuring and Related Activities [Abstract] |
Restructuring and Integration Costs | Restructuring and Integration Costs 2014 Sauflon Integration Plan During the fiscal fourth quarter of 2014, in connection with the Sauflon acquisition, our CooperVision business unit initiated restructuring and integration activities to optimize operational synergies of the combined companies. These activities include workforce reductions, consolidation of duplicative facilities and product rationalization. We estimate the total restructuring costs under this plan to be $112.0 million. The $8.0 million increase over our fiscal third quarter estimate relates to additional product rationalization and related equipment disposals and accelerated depreciation, primarily related to our hydrogel contact lenses, based on our review of products, materials and manufacturing processes of Sauflon. We expect to be substantially complete with activities related to operating expenses in our fiscal first quarter of 2016, and to incur costs related to manufacturing activities through the end of fiscal 2016. These estimated costs include approximately $89.0 million associated with assets, including product rationalization and related equipment disposals and accelerated depreciation, about $19.0 million associated with employee termination costs and about $4.0 million associated with facility lease termination costs. In fiscal 2015, we recorded in cost of sales $57.7 million of expense, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. We recorded in cost of sales $4.0 million of employee termination costs. We reduced in selling, general and administrative expense, the accrued employee termination costs by $7.2 million, based on current estimates of the expected costs and the results of voluntary terminations; and we recorded $0.4 million of expense for lease termination costs. We recorded in research and development expense $0.7 million of employee termination costs. In addition, CooperVision incurred $35.2 million of integration costs in fiscal 2015, included in operating expenses. In fiscal 2014, we recorded restructuring charges of $20.3 million for employee termination costs; $15.3 million for product rationalization, including inventory write-offs and production-related asset impairments, primarily related to our Avaira toric contact lenses, based on our review of products, materials and manufacturing processes of Sauflon; and $0.5 million of lease termination costs for facility closures. In addition, CooperVision incurred $2.8 million of integration costs recorded in selling, general and administrative expense. Of the employee termination costs, $19.7 million are recorded in selling, general and administrative expense and $0.6 million in research and development expense. The product rationalization costs are recorded in cost of sales. The lease termination costs and other related costs are recorded in selling, general and administrative expense. A summary of the total restructuring costs by major component recognized for the fiscal years ended October 31, 2015, and October 31, 2014, is as follows:
(In millions) | Employee-related |  | Facilities-related |  | Product Rationalization |  | Total
Amounts incurred in: |  |  |  |  |  |  |
Year ended October 31, 2014 | $ | 20.3 |  |  | $ | 0.5 |  |  | $ | 15.3 |  |  | $ | 36.1 |
Year ended October 31, 2015 | (2.5 | ) |  | 0.4 |  |  | 57.7 |  |  | 55.6 |
Cumulative amounts incurred as of October 31, 2015 | $ | 17.8 |  |  | $ | 0.9 |  |  | $ | 73.0 |  |  | $ | 91.7 |
The following table summarizes the restructuring activities by major component:
(In millions) | Employee-related |  | Facilities-related |  | Product Rationalization |  | Total
Additions during fiscal 2014 | $ | 20.3 |  |  | $ | 0.5 |  |  | $ | 15.3 |  |  | $ | 36.1 |
Payments during the fiscal year | (0.4 | ) |  | — |  |  | — |  |  | (0.4 | )
Non-cash adjustments (b) | — |  |  | — |  |  | (15.3 | ) |  | (15.3 | )
Balance at October 31, 2014 | $ | 19.9 |  |  | $ | 0.5 |  |  | $ | — |  |  | $ | 20.4 |
(Reductions) additions during fiscal 2015 | (2.5 | ) |  | 0.4 |  |  | 57.7 |  |  | 55.6 |
Payments during the fiscal year | (9.0 | ) |  | (0.4 | ) |  | — |  |  | (9.4 | )
Non-cash adjustments (a) (b) | 0.2 |  |  | (0.2 | ) |  | (57.7 | ) |  | (57.7 | )
Balance as of October 31, 2015 | $ | 8.6 |  |  | $ | 0.3 |  |  | $ | — |  |  | $ | 8.9 |
(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment. (b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.

X
- Definition The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration